DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Onyx Biotec Limited — Updates

NSE 1 hr ago·7 Oct 2026, 5:51 am

Onyx Biotec

Onyx Biotec has informed stock exchanges that VC Corporate Advisors has submitted a Letter of Offer. This document outlines the terms and conditions for a proposed transaction, though the specific details of the deal have not been disclosed in the public notice.

This development signals that the company is actively exploring a strategic move, such as a merger, acquisition, or share sale. For investors, this is a significant event that could alter the company's ownership structure or business direction, making it a key development to monitor closely.

Investors should watch for the official filing of the definitive agreement and any subsequent announcements regarding the transaction's value and timeline. The market will react to the clarity and scope of the offer, so staying updated on official disclosures is essential.